Literature DB >> 15476744

Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells.

Daniël Duijsings1, Martin Houweling, Arie B Vaandrager, Jan A Mol, Katja J Teerds.   

Abstract

Hexadecylphosphocholine (HePC, Miltefosine) is an antitumour phospholipid and known inducer of apoptosis in human breast cancer cells. The mechanism underlying the induction of cell death by HePC, however, is not clear yet. In this study, we have investigated the cytotoxic effects of HePC on canine mammary tumour cells (CMTs) in vitro. Upon addition of HePC, CMTs rapidly exhibited several features that resembled apoptotic cell death. Cells showed externalization of phosphatidylserine, a hallmark of apoptosis, within 5 min after addition of HePC at concentrations as low as 10 microM. Furthermore, rapid swelling of mitochondria was observed. Rounding and detachment of cells followed within 30 min. However, fragmentation of nuclear DNA could not be observed. Overall, HePC was shown to induce a type of cell death in CMTs that in some aspects resembles apoptosis, though the process proceeds much more rapidly than reported for other tumour cell lines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476744     DOI: 10.1016/j.ejphar.2004.09.015

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  1 in total

1.  Targeting the PI3K/Akt cell survival pathway to induce cell death of HIV-1 infected macrophages with alkylphospholipid compounds.

Authors:  Amanda Lucas; Yuri Kim; Omayra Rivera-Pabon; Sunju Chae; Dong-Hyun Kim; Baek Kim
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.